Glenmark gets ANDA approval for Saxagliptin Tablets, 2.5 mg and 5 mg EP News Bureau Aug 1, 2023 Glenmark’s Saxagliptin Tablets, 2.5 mg and 5 mg, will be distributed in the US by Glenmark Pharma, USA
Glenmark Pharma hosts drug discovery workshop for Sion Hospital students EP News Bureau Jul 12, 2023 The tour was aimed at encouraging medical students to explore new horizons in their academic journey
Glenmark reduces cost of Trastuzumab treatment in India EP News Bureau Jun 15, 2023 A 440 mg vial of Trumab will be priced at Rs 15,749, which makes it the most affordable option available currently in the country
Glenmark Foundation concludes fifth season of ‘Meri Poushtik Rasoi’ National Cooking… EP News Bureau May 12, 2023 As a pan-India initiative, it aimed at addressing the issue of malnutrition through the promotion of nutrition-rich native recipes
Glenmark Pharma launches Bumetanide injection vials EP News Bureau Jan 10, 2023 According to IQVIA sales data for the 12-month period ending November 2022, the Bumex injection, 0.25 mg/mL market achieved annual…
JB Pharma to acquire the Razel franchise for Rs 314 crore EP News Bureau Dec 15, 2022 The acquisition marks JB Pharma’s entry into 'statin’ segment which is the largest group in the cardiac therapy
Glenmark Pharma reaches settlement agreement with Pfizer for Axitinib tablets EP News Bureau Nov 22, 2022 Glenmark Pharma earlier had also received tentative approval by the US Food and Drug Administration (FDA) for their generic…
US FDA gives final approval to Glenmark Pharma’s Sodium Phenylbutyrate tablets EP News Bureau Nov 3, 2022 The tablets will be distributed in the US by Glenmark Pharma Inc., USA
Glenmark launches Teneligliptin+Dapagliflozin Fixed-Dose Combination for adults with type-II… EP News Bureau Oct 20, 2022 The medication will be marketed under brand name Zita D
Glenmark, Strides Pharma and Cipla recall products in US Press Trust of India Aug 22, 2022 The recall has taken place due to manufacturing issues